Clinical Trial Update: Olverembatinib Combined With Venetoclax and Azacitidine in Blast Phase Ph Chromosome-positive CML [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating the combination of olverembatinib with venetoclax and azacitidine for chronic myeloid leukemia in blast crisis is currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia in Blast Crisis

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• Olverembatinib (Olverembatinib)
• Venetoclax (venetoclax)

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: CML,Blast Phase | Phase 1, Phase 2 | Status: RECRUITING